Central nervous system histoplasmosis in a European immunocompetent patient: A challenging diagnosis
Rev Neurol (Paris). 2021 Mar 31:S0035-3787(21)00460-4. doi: 10.1016/j.neurol.2020.11.014. Online ahead of print.NO ABSTRACTPMID:33812675 | DOI:10.1016/j.neurol.2020.11.014 (Source: Revue Neurologique)
Source: Revue Neurologique - April 4, 2021 Category: Neurology Authors: A-C Wemel M Milet S Lovi Source Type: research

Drug safety in multiple sclerosis: From reporting to signal detection and benefit-risk management
CONCLUSION: Improvement of the PV system procedures has led to significant progress in the detection of signals, allowing better assessment of the benefit-risk balance and the implementation of risk management plans for MS treatments. The involvement of neurologists is essential to improve knowledge on the benefit-risk balance of these drugs. In addition, adverse drug reactions reporting by persons with MS should be encouraged.PMID:33812676 | DOI:10.1016/j.neurol.2021.01.009 (Source: Revue Neurologique)
Source: Revue Neurologique - April 4, 2021 Category: Neurology Authors: L Peyro-Saint-Paul S Fedrizzi G Defer Source Type: research

Central nervous system histoplasmosis in a European immunocompetent patient: A challenging diagnosis
Rev Neurol (Paris). 2021 Mar 31:S0035-3787(21)00460-4. doi: 10.1016/j.neurol.2020.11.014. Online ahead of print.NO ABSTRACTPMID:33812675 | DOI:10.1016/j.neurol.2020.11.014 (Source: Revue Neurologique)
Source: Revue Neurologique - April 4, 2021 Category: Neurology Authors: A-C Wemel M Milet S Lovi Source Type: research

Drug safety in multiple sclerosis: From reporting to signal detection and benefit-risk management
CONCLUSION: Improvement of the PV system procedures has led to significant progress in the detection of signals, allowing better assessment of the benefit-risk balance and the implementation of risk management plans for MS treatments. The involvement of neurologists is essential to improve knowledge on the benefit-risk balance of these drugs. In addition, adverse drug reactions reporting by persons with MS should be encouraged.PMID:33812676 | DOI:10.1016/j.neurol.2021.01.009 (Source: Revue Neurologique)
Source: Revue Neurologique - April 4, 2021 Category: Neurology Authors: L Peyro-Saint-Paul S Fedrizzi G Defer Source Type: research

Central nervous system histoplasmosis in a European immunocompetent patient: A challenging diagnosis
Rev Neurol (Paris). 2021 Mar 31:S0035-3787(21)00460-4. doi: 10.1016/j.neurol.2020.11.014. Online ahead of print.NO ABSTRACTPMID:33812675 | DOI:10.1016/j.neurol.2020.11.014 (Source: Revue Neurologique)
Source: Revue Neurologique - April 4, 2021 Category: Neurology Authors: A-C Wemel M Milet S Lovi Source Type: research

Drug safety in multiple sclerosis: From reporting to signal detection and benefit-risk management
CONCLUSION: Improvement of the PV system procedures has led to significant progress in the detection of signals, allowing better assessment of the benefit-risk balance and the implementation of risk management plans for MS treatments. The involvement of neurologists is essential to improve knowledge on the benefit-risk balance of these drugs. In addition, adverse drug reactions reporting by persons with MS should be encouraged.PMID:33812676 | DOI:10.1016/j.neurol.2021.01.009 (Source: Revue Neurologique)
Source: Revue Neurologique - April 4, 2021 Category: Neurology Authors: L Peyro-Saint-Paul S Fedrizzi G Defer Source Type: research

Central nervous system histoplasmosis in a European immunocompetent patient: A challenging diagnosis
Rev Neurol (Paris). 2021 Mar 31:S0035-3787(21)00460-4. doi: 10.1016/j.neurol.2020.11.014. Online ahead of print.NO ABSTRACTPMID:33812675 | DOI:10.1016/j.neurol.2020.11.014 (Source: Revue Neurologique)
Source: Revue Neurologique - April 4, 2021 Category: Neurology Authors: A-C Wemel M Milet S Lovi Source Type: research

Drug safety in multiple sclerosis: From reporting to signal detection and benefit-risk management
CONCLUSION: Improvement of the PV system procedures has led to significant progress in the detection of signals, allowing better assessment of the benefit-risk balance and the implementation of risk management plans for MS treatments. The involvement of neurologists is essential to improve knowledge on the benefit-risk balance of these drugs. In addition, adverse drug reactions reporting by persons with MS should be encouraged.PMID:33812676 | DOI:10.1016/j.neurol.2021.01.009 (Source: Revue Neurologique)
Source: Revue Neurologique - April 4, 2021 Category: Neurology Authors: L Peyro-Saint-Paul S Fedrizzi G Defer Source Type: research

Central nervous system histoplasmosis in a European immunocompetent patient: A challenging diagnosis
Rev Neurol (Paris). 2021 Mar 31:S0035-3787(21)00460-4. doi: 10.1016/j.neurol.2020.11.014. Online ahead of print.NO ABSTRACTPMID:33812675 | DOI:10.1016/j.neurol.2020.11.014 (Source: Revue Neurologique)
Source: Revue Neurologique - April 4, 2021 Category: Neurology Authors: A-C Wemel M Milet S Lovi Source Type: research

Drug safety in multiple sclerosis: From reporting to signal detection and benefit-risk management
CONCLUSION: Improvement of the PV system procedures has led to significant progress in the detection of signals, allowing better assessment of the benefit-risk balance and the implementation of risk management plans for MS treatments. The involvement of neurologists is essential to improve knowledge on the benefit-risk balance of these drugs. In addition, adverse drug reactions reporting by persons with MS should be encouraged.PMID:33812676 | DOI:10.1016/j.neurol.2021.01.009 (Source: Revue Neurologique)
Source: Revue Neurologique - April 4, 2021 Category: Neurology Authors: L Peyro-Saint-Paul S Fedrizzi G Defer Source Type: research

Central nervous system histoplasmosis in a European immunocompetent patient: A challenging diagnosis
Rev Neurol (Paris). 2021 Mar 31:S0035-3787(21)00460-4. doi: 10.1016/j.neurol.2020.11.014. Online ahead of print.NO ABSTRACTPMID:33812675 | DOI:10.1016/j.neurol.2020.11.014 (Source: Revue Neurologique)
Source: Revue Neurologique - April 4, 2021 Category: Neurology Authors: A-C Wemel M Milet S Lovi Source Type: research

Drug safety in multiple sclerosis: From reporting to signal detection and benefit-risk management
CONCLUSION: Improvement of the PV system procedures has led to significant progress in the detection of signals, allowing better assessment of the benefit-risk balance and the implementation of risk management plans for MS treatments. The involvement of neurologists is essential to improve knowledge on the benefit-risk balance of these drugs. In addition, adverse drug reactions reporting by persons with MS should be encouraged.PMID:33812676 | DOI:10.1016/j.neurol.2021.01.009 (Source: Revue Neurologique)
Source: Revue Neurologique - April 4, 2021 Category: Neurology Authors: L Peyro-Saint-Paul S Fedrizzi G Defer Source Type: research

Central nervous system histoplasmosis in a European immunocompetent patient: A challenging diagnosis
Rev Neurol (Paris). 2021 Mar 31:S0035-3787(21)00460-4. doi: 10.1016/j.neurol.2020.11.014. Online ahead of print.NO ABSTRACTPMID:33812675 | DOI:10.1016/j.neurol.2020.11.014 (Source: Revue Neurologique)
Source: Revue Neurologique - April 4, 2021 Category: Neurology Authors: A-C Wemel M Milet S Lovi Source Type: research

Drug safety in multiple sclerosis: From reporting to signal detection and benefit-risk management
CONCLUSION: Improvement of the PV system procedures has led to significant progress in the detection of signals, allowing better assessment of the benefit-risk balance and the implementation of risk management plans for MS treatments. The involvement of neurologists is essential to improve knowledge on the benefit-risk balance of these drugs. In addition, adverse drug reactions reporting by persons with MS should be encouraged.PMID:33812676 | DOI:10.1016/j.neurol.2021.01.009 (Source: Revue Neurologique)
Source: Revue Neurologique - April 4, 2021 Category: Neurology Authors: L Peyro-Saint-Paul S Fedrizzi G Defer Source Type: research

Central nervous system histoplasmosis in a European immunocompetent patient: A challenging diagnosis
Rev Neurol (Paris). 2021 Mar 31:S0035-3787(21)00460-4. doi: 10.1016/j.neurol.2020.11.014. Online ahead of print.NO ABSTRACTPMID:33812675 | DOI:10.1016/j.neurol.2020.11.014 (Source: Revue Neurologique)
Source: Revue Neurologique - April 4, 2021 Category: Neurology Authors: A-C Wemel M Milet S Lovi Source Type: research

Drug safety in multiple sclerosis: From reporting to signal detection and benefit-risk management
CONCLUSION: Improvement of the PV system procedures has led to significant progress in the detection of signals, allowing better assessment of the benefit-risk balance and the implementation of risk management plans for MS treatments. The involvement of neurologists is essential to improve knowledge on the benefit-risk balance of these drugs. In addition, adverse drug reactions reporting by persons with MS should be encouraged.PMID:33812676 | DOI:10.1016/j.neurol.2021.01.009 (Source: Revue Neurologique)
Source: Revue Neurologique - April 4, 2021 Category: Neurology Authors: L Peyro-Saint-Paul S Fedrizzi G Defer Source Type: research

Central nervous system histoplasmosis in a European immunocompetent patient: A challenging diagnosis
Rev Neurol (Paris). 2021 Mar 31:S0035-3787(21)00460-4. doi: 10.1016/j.neurol.2020.11.014. Online ahead of print.NO ABSTRACTPMID:33812675 | DOI:10.1016/j.neurol.2020.11.014 (Source: Revue Neurologique)
Source: Revue Neurologique - April 4, 2021 Category: Neurology Authors: A-C Wemel M Milet S Lovi Source Type: research

Drug safety in multiple sclerosis: From reporting to signal detection and benefit-risk management
CONCLUSION: Improvement of the PV system procedures has led to significant progress in the detection of signals, allowing better assessment of the benefit-risk balance and the implementation of risk management plans for MS treatments. The involvement of neurologists is essential to improve knowledge on the benefit-risk balance of these drugs. In addition, adverse drug reactions reporting by persons with MS should be encouraged.PMID:33812676 | DOI:10.1016/j.neurol.2021.01.009 (Source: Revue Neurologique)
Source: Revue Neurologique - April 4, 2021 Category: Neurology Authors: L Peyro-Saint-Paul S Fedrizzi G Defer Source Type: research

Central nervous system histoplasmosis in a European immunocompetent patient: A challenging diagnosis
Rev Neurol (Paris). 2021 Mar 31:S0035-3787(21)00460-4. doi: 10.1016/j.neurol.2020.11.014. Online ahead of print.NO ABSTRACTPMID:33812675 | DOI:10.1016/j.neurol.2020.11.014 (Source: Revue Neurologique)
Source: Revue Neurologique - April 4, 2021 Category: Neurology Authors: A-C Wemel M Milet S Lovi Source Type: research

Drug safety in multiple sclerosis: From reporting to signal detection and benefit-risk management
CONCLUSION: Improvement of the PV system procedures has led to significant progress in the detection of signals, allowing better assessment of the benefit-risk balance and the implementation of risk management plans for MS treatments. The involvement of neurologists is essential to improve knowledge on the benefit-risk balance of these drugs. In addition, adverse drug reactions reporting by persons with MS should be encouraged.PMID:33812676 | DOI:10.1016/j.neurol.2021.01.009 (Source: Revue Neurologique)
Source: Revue Neurologique - April 4, 2021 Category: Neurology Authors: L Peyro-Saint-Paul S Fedrizzi G Defer Source Type: research

New advances in Amyotrophic Lateral Sclerosis genetics: Towards gene therapy opportunities for familial and young cases
Rev Neurol (Paris). 2021 Mar 30:S0035-3787(21)00456-2. doi: 10.1016/j.neurol.2021.01.008. Online ahead of print.ABSTRACTDue to novel gene therapy opportunities, genetic screening is no longer restricted to familial cases of ALS (FALS) cases but also aplies to the sporadic populations (SALS). Screening of four main genes (C9orf72, SOD1, TARDBP and FUS) identified the causes in 15% of Amyotrophic Lateral Sclerosis (ALS) patients (two third of the familial cases and 8% of the sporadic ones) but their respective contribution to ALS phenotype varies according the age of disease onset. The genetic overlap between ALS and other d...
Source: Revue Neurologique - April 3, 2021 Category: Neurology Authors: M-D-M Amador F Muratet E Teyssou S Boill ée S Millecamps Source Type: research

One case of orbital apex syndrome caused by small cell lung cancer metastasis
Rev Neurol (Paris). 2021 Mar 30:S0035-3787(21)00452-5. doi: 10.1016/j.neurol.2020.11.010. Online ahead of print.NO ABSTRACTPMID:33810838 | DOI:10.1016/j.neurol.2020.11.010 (Source: Revue Neurologique)
Source: Revue Neurologique - April 3, 2021 Category: Neurology Authors: L Xu M Yu X-R Chen L-L Li Q-R Ouyang Q Xiong Source Type: research

Severe migraine and its control: A proposal for definitions and consequences for care
Rev Neurol (Paris). 2021 Mar 30:S0035-3787(21)00457-4. doi: 10.1016/j.neurol.2020.11.012. Online ahead of print.ABSTRACTCurrently many patients with severe migraine do not receive appropriate treatment and are never referred to specialist headache centres. On the other hand, specialist headache centres are frequently attended by patients whose migraines could be managed adequately in the community. One reason for this may be the absence of standardised definitions of migraine severity and control and of a treatment algorithm for orientating difficult-to-treat patients to specialist headache centres. Based on a review of th...
Source: Revue Neurologique - April 3, 2021 Category: Neurology Authors: Anne Donnet Anne Ducros Fran çoise Radat Bashar Allaf Isabelle Chouette Michel Lanteri-Minet Source Type: research

New advances in Amyotrophic Lateral Sclerosis genetics: Towards gene therapy opportunities for familial and young cases
Rev Neurol (Paris). 2021 Mar 30:S0035-3787(21)00456-2. doi: 10.1016/j.neurol.2021.01.008. Online ahead of print.ABSTRACTDue to novel gene therapy opportunities, genetic screening is no longer restricted to familial cases of ALS (FALS) cases but also aplies to the sporadic populations (SALS). Screening of four main genes (C9orf72, SOD1, TARDBP and FUS) identified the causes in 15% of Amyotrophic Lateral Sclerosis (ALS) patients (two third of the familial cases and 8% of the sporadic ones) but their respective contribution to ALS phenotype varies according the age of disease onset. The genetic overlap between ALS and other d...
Source: Revue Neurologique - April 3, 2021 Category: Neurology Authors: M-D-M Amador F Muratet E Teyssou S Boill ée S Millecamps Source Type: research

One case of orbital apex syndrome caused by small cell lung cancer metastasis
Rev Neurol (Paris). 2021 Mar 30:S0035-3787(21)00452-5. doi: 10.1016/j.neurol.2020.11.010. Online ahead of print.NO ABSTRACTPMID:33810838 | DOI:10.1016/j.neurol.2020.11.010 (Source: Revue Neurologique)
Source: Revue Neurologique - April 3, 2021 Category: Neurology Authors: L Xu M Yu X-R Chen L-L Li Q-R Ouyang Q Xiong Source Type: research

Severe migraine and its control: A proposal for definitions and consequences for care
Rev Neurol (Paris). 2021 Mar 30:S0035-3787(21)00457-4. doi: 10.1016/j.neurol.2020.11.012. Online ahead of print.ABSTRACTCurrently many patients with severe migraine do not receive appropriate treatment and are never referred to specialist headache centres. On the other hand, specialist headache centres are frequently attended by patients whose migraines could be managed adequately in the community. One reason for this may be the absence of standardised definitions of migraine severity and control and of a treatment algorithm for orientating difficult-to-treat patients to specialist headache centres. Based on a review of th...
Source: Revue Neurologique - April 3, 2021 Category: Neurology Authors: Anne Donnet Anne Ducros Fran çoise Radat Bashar Allaf Isabelle Chouette Michel Lanteri-Minet Source Type: research

Primary intracranial germinoma mimicking meningioma in an elderly patient
Rev Neurol (Paris). 2021 Mar 29:S0035-3787(21)00463-X. doi: 10.1016/j.neurol.2020.11.016. Online ahead of print.NO ABSTRACTPMID:33795143 | DOI:10.1016/j.neurol.2020.11.016 (Source: Revue Neurologique)
Source: Revue Neurologique - April 2, 2021 Category: Neurology Authors: A Jacques L Thomas T Fenouil F Fomekong R Ameli F Ducray Source Type: research

Degenerative cervical myelopathy
Rev Neurol (Paris). 2021 Mar 26:S0035-3787(21)00462-8. doi: 10.1016/j.neurol.2020.11.015. Online ahead of print.ABSTRACTDegenerative cervical myelopathy (DCM) frequently leads to severe neurologic disability but is still frequently underdiagnosed. One explanation may be the variability of the symptoms presented by the patients, from paresthesia to quadriplegia, making it another great masquerader. What do we know? How can we manage better these patients? We will review the keys points concerning its challenging diagnosis (clinical and radiologic), some of the recent discoveries about DCM, notably the underlying genetic mut...
Source: Revue Neurologique - March 30, 2021 Category: Neurology Authors: L Marie-Hardy H Pascal-Moussellard Source Type: research

Polycythemia vera complicated by chorea: A case report and the review of Chinese and international literature
Rev Neurol (Paris). 2021 Mar 26:S0035-3787(21)00459-8. doi: 10.1016/j.neurol.2020.11.013. Online ahead of print.NO ABSTRACTPMID:33781561 | DOI:10.1016/j.neurol.2020.11.013 (Source: Revue Neurologique)
Source: Revue Neurologique - March 30, 2021 Category: Neurology Authors: H K Raza T Chansysouphanthong S Singh A Amir M W Raza Z Zhang G Cui H Chen Source Type: research

Therapeutic news in ALS
We present in this review the various treatment options currently being developed for ALS, with an emphasis on the range of therapeutic approaches being explored, from old drugs tested in a new indication to innovative drugs obtained via biotechnology or gene therapy.PMID:33781562 | DOI:10.1016/j.neurol.2020.12.003 (Source: Revue Neurologique)
Source: Revue Neurologique - March 30, 2021 Category: Neurology Authors: P Corcia S Beltran S E Bakkouche P Couratier Source Type: research

Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) secondary to an acute cranial nerve meningoradiculitis
Rev Neurol (Paris). 2021 Mar 26:S0035-3787(21)00455-0. doi: 10.1016/j.neurol.2020.11.011. Online ahead of print.NO ABSTRACTPMID:33781563 | DOI:10.1016/j.neurol.2020.11.011 (Source: Revue Neurologique)
Source: Revue Neurologique - March 30, 2021 Category: Neurology Authors: J-B Davion C Tard L Defebvre S Nguyen The Tich S Sanges C Lucas Source Type: research

Spinal cord arterio-venous shunts: From classification to therapeutic management
Rev Neurol (Paris). 2021 Mar 26:S0035-3787(21)00461-6. doi: 10.1016/j.neurol.2021.01.010. Online ahead of print.ABSTRACTSpinal Cord Arterio-Venous shunts (SCAVSs) are a rare disease. The aim of this paper is to describe how we classify and consider management of SCAVSs in relation to the location of the shunt focusing mainly on intradural SCAVSs. The anatomical features of the SCAVSs together with data provided by MRI and CT scans allow identification of four types of SCAVSs: paraspinal, epidural, dural and intradural ones. Clinical and neuroradiologic characteristics are described for each entity as well as the therapeuti...
Source: Revue Neurologique - March 30, 2021 Category: Neurology Authors: A Consoli O Coskun F Di Maria J Gratieux S Condette-Auliac S Smadja A Boulin G Rodesch Source Type: research

Degenerative cervical myelopathy
Rev Neurol (Paris). 2021 Mar 26:S0035-3787(21)00462-8. doi: 10.1016/j.neurol.2020.11.015. Online ahead of print.ABSTRACTDegenerative cervical myelopathy (DCM) frequently leads to severe neurologic disability but is still frequently underdiagnosed. One explanation may be the variability of the symptoms presented by the patients, from paresthesia to quadriplegia, making it another great masquerader. What do we know? How can we manage better these patients? We will review the keys points concerning its challenging diagnosis (clinical and radiologic), some of the recent discoveries about DCM, notably the underlying genetic mut...
Source: Revue Neurologique - March 30, 2021 Category: Neurology Authors: L Marie-Hardy H Pascal-Moussellard Source Type: research

Polycythemia vera complicated by chorea: A case report and the review of Chinese and international literature
Rev Neurol (Paris). 2021 Mar 26:S0035-3787(21)00459-8. doi: 10.1016/j.neurol.2020.11.013. Online ahead of print.NO ABSTRACTPMID:33781561 | DOI:10.1016/j.neurol.2020.11.013 (Source: Revue Neurologique)
Source: Revue Neurologique - March 30, 2021 Category: Neurology Authors: H K Raza T Chansysouphanthong S Singh A Amir M W Raza Z Zhang G Cui H Chen Source Type: research

Therapeutic news in ALS
We present in this review the various treatment options currently being developed for ALS, with an emphasis on the range of therapeutic approaches being explored, from old drugs tested in a new indication to innovative drugs obtained via biotechnology or gene therapy.PMID:33781562 | DOI:10.1016/j.neurol.2020.12.003 (Source: Revue Neurologique)
Source: Revue Neurologique - March 30, 2021 Category: Neurology Authors: P Corcia S Beltran S E Bakkouche P Couratier Source Type: research

Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) secondary to an acute cranial nerve meningoradiculitis
Rev Neurol (Paris). 2021 Mar 26:S0035-3787(21)00455-0. doi: 10.1016/j.neurol.2020.11.011. Online ahead of print.NO ABSTRACTPMID:33781563 | DOI:10.1016/j.neurol.2020.11.011 (Source: Revue Neurologique)
Source: Revue Neurologique - March 30, 2021 Category: Neurology Authors: J-B Davion C Tard L Defebvre S Nguyen The Tich S Sanges C Lucas Source Type: research

Spinal cord arterio-venous shunts: From classification to therapeutic management
Rev Neurol (Paris). 2021 Mar 26:S0035-3787(21)00461-6. doi: 10.1016/j.neurol.2021.01.010. Online ahead of print.ABSTRACTSpinal Cord Arterio-Venous shunts (SCAVSs) are a rare disease. The aim of this paper is to describe how we classify and consider management of SCAVSs in relation to the location of the shunt focusing mainly on intradural SCAVSs. The anatomical features of the SCAVSs together with data provided by MRI and CT scans allow identification of four types of SCAVSs: paraspinal, epidural, dural and intradural ones. Clinical and neuroradiologic characteristics are described for each entity as well as the therapeuti...
Source: Revue Neurologique - March 30, 2021 Category: Neurology Authors: A Consoli O Coskun F Di Maria J Gratieux S Condette-Auliac S Smadja A Boulin G Rodesch Source Type: research

Degenerative cervical myelopathy
Rev Neurol (Paris). 2021 Mar 26:S0035-3787(21)00462-8. doi: 10.1016/j.neurol.2020.11.015. Online ahead of print.ABSTRACTDegenerative cervical myelopathy (DCM) frequently leads to severe neurologic disability but is still frequently underdiagnosed. One explanation may be the variability of the symptoms presented by the patients, from paresthesia to quadriplegia, making it another great masquerader. What do we know? How can we manage better these patients? We will review the keys points concerning its challenging diagnosis (clinical and radiologic), some of the recent discoveries about DCM, notably the underlying genetic mut...
Source: Revue Neurologique - March 30, 2021 Category: Neurology Authors: L Marie-Hardy H Pascal-Moussellard Source Type: research

Polycythemia vera complicated by chorea: A case report and the review of Chinese and international literature
Rev Neurol (Paris). 2021 Mar 26:S0035-3787(21)00459-8. doi: 10.1016/j.neurol.2020.11.013. Online ahead of print.NO ABSTRACTPMID:33781561 | DOI:10.1016/j.neurol.2020.11.013 (Source: Revue Neurologique)
Source: Revue Neurologique - March 30, 2021 Category: Neurology Authors: H K Raza T Chansysouphanthong S Singh A Amir M W Raza Z Zhang G Cui H Chen Source Type: research

Therapeutic news in ALS
We present in this review the various treatment options currently being developed for ALS, with an emphasis on the range of therapeutic approaches being explored, from old drugs tested in a new indication to innovative drugs obtained via biotechnology or gene therapy.PMID:33781562 | DOI:10.1016/j.neurol.2020.12.003 (Source: Revue Neurologique)
Source: Revue Neurologique - March 30, 2021 Category: Neurology Authors: P Corcia S Beltran S E Bakkouche P Couratier Source Type: research

Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) secondary to an acute cranial nerve meningoradiculitis
Rev Neurol (Paris). 2021 Mar 26:S0035-3787(21)00455-0. doi: 10.1016/j.neurol.2020.11.011. Online ahead of print.NO ABSTRACTPMID:33781563 | DOI:10.1016/j.neurol.2020.11.011 (Source: Revue Neurologique)
Source: Revue Neurologique - March 30, 2021 Category: Neurology Authors: J-B Davion C Tard L Defebvre S Nguyen The Tich S Sanges C Lucas Source Type: research

Spinal cord arterio-venous shunts: From classification to therapeutic management
Rev Neurol (Paris). 2021 Mar 26:S0035-3787(21)00461-6. doi: 10.1016/j.neurol.2021.01.010. Online ahead of print.ABSTRACTSpinal Cord Arterio-Venous shunts (SCAVSs) are a rare disease. The aim of this paper is to describe how we classify and consider management of SCAVSs in relation to the location of the shunt focusing mainly on intradural SCAVSs. The anatomical features of the SCAVSs together with data provided by MRI and CT scans allow identification of four types of SCAVSs: paraspinal, epidural, dural and intradural ones. Clinical and neuroradiologic characteristics are described for each entity as well as the therapeuti...
Source: Revue Neurologique - March 30, 2021 Category: Neurology Authors: A Consoli O Coskun F Di Maria J Gratieux S Condette-Auliac S Smadja A Boulin G Rodesch Source Type: research

The future of ALS might move towards Genetic Therapy
Rev Neurol (Paris). 2021 Mar 25:S0035-3787(21)00454-9. doi: 10.1016/j.neurol.2021.01.007. Online ahead of print.NO ABSTRACTPMID:33775441 | DOI:10.1016/j.neurol.2021.01.007 (Source: Revue Neurologique)
Source: Revue Neurologique - March 29, 2021 Category: Neurology Authors: P Corcia P Couratier P Vourc'h Source Type: research

Spinal infarcts
Rev Neurol (Paris). 2021 Mar 25:S0035-3787(21)00453-7. doi: 10.1016/j.neurol.2020.12.002. Online ahead of print.ABSTRACTCompared to cerebral ischaemia, the frequency of spinal cord ischaemia is rare. Spinal infarcts lead to various types of neurological deficits, usually consisting of an abrupt and complete tetra- or paraplegia. Magnetic resonance imaging is the most valuable tool to show the infarct and to rule out other causes of acute spinal cord syndromes., such as myelitis or acute compressions. Nowadays, in western countries, most spinal cord infarcts are due to aortic diseases (atherosclerosis, aneurysm, dissection)...
Source: Revue Neurologique - March 29, 2021 Category: Neurology Authors: D Leys J-P Pruvo Source Type: research

The future of ALS might move towards Genetic Therapy
Rev Neurol (Paris). 2021 Mar 25:S0035-3787(21)00454-9. doi: 10.1016/j.neurol.2021.01.007. Online ahead of print.NO ABSTRACTPMID:33775441 | DOI:10.1016/j.neurol.2021.01.007 (Source: Revue Neurologique)
Source: Revue Neurologique - March 29, 2021 Category: Neurology Authors: P Corcia P Couratier P Vourc'h Source Type: research

Spinal infarcts
Rev Neurol (Paris). 2021 Mar 25:S0035-3787(21)00453-7. doi: 10.1016/j.neurol.2020.12.002. Online ahead of print.ABSTRACTCompared to cerebral ischaemia, the frequency of spinal cord ischaemia is rare. Spinal infarcts lead to various types of neurological deficits, usually consisting of an abrupt and complete tetra- or paraplegia. Magnetic resonance imaging is the most valuable tool to show the infarct and to rule out other causes of acute spinal cord syndromes., such as myelitis or acute compressions. Nowadays, in western countries, most spinal cord infarcts are due to aortic diseases (atherosclerosis, aneurysm, dissection)...
Source: Revue Neurologique - March 29, 2021 Category: Neurology Authors: D Leys J-P Pruvo Source Type: research

Jacques Glowinski
Rev Neurol (Paris). 2021 Mar;177(3):159-161. doi: 10.1016/j.neurol.2021.02.382.NO ABSTRACTPMID:33706969 | DOI:10.1016/j.neurol.2021.02.382 (Source: Revue Neurologique)
Source: Revue Neurologique - March 12, 2021 Category: Neurology Authors: Y Agid Source Type: research

Neurology and pregnancy: The delivery
Rev Neurol (Paris). 2021 Mar;177(3):166-167. doi: 10.1016/j.neurol.2021.02.383.NO ABSTRACTPMID:33706970 | DOI:10.1016/j.neurol.2021.02.383 (Source: Revue Neurologique)
Source: Revue Neurologique - March 12, 2021 Category: Neurology Authors: M Anheim Source Type: research

Jacques Glowinski
Rev Neurol (Paris). 2021 Mar;177(3):159-161. doi: 10.1016/j.neurol.2021.02.382.NO ABSTRACTPMID:33706969 | DOI:10.1016/j.neurol.2021.02.382 (Source: Revue Neurologique)
Source: Revue Neurologique - March 12, 2021 Category: Neurology Authors: Y Agid Source Type: research